NCT01038427 - A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis | Biotech Hunter

Enrollment

795

Participants

Timeline

Start Date

December 2, 2009

Primary Completion Date

February 16, 2010

Study Completion Date

February 16, 2010

Conditions

Rhinitis, Allergic, Seasonal

Interventions

DRUG

Mometasone furoate 50 mcg/actuation nasal spray (Lek Pharmaceuticals)

Mometasone nasal spray administered once daily at a dose of 200 mcg (4 actuations) for 14 days.

DRUG

Mometasone furoate (Nasonex®) 50 mcg/actuation nasal spray

Mometasone nasal spray administered once daily at a dose of 200 mcg (4 actuations) for 14 days.

DRUG

Placebo

Placebo nasal spray administered once daily (4 actuations) for 14 days.

Trial Locations (8)

Waco

Kerrville

Sylvana Research, San Antonio

San Antonio

Live Oak

New Braunfels

Austin

Austin